Inflammatory response to isocyanates and onset of genomic instability in cultured human lung fibroblasts

Genetics and Molecular Research

Volumn 8, Issue 1, 2009, Pages 129-143

  Mishra, P K ^a   Bhargava, A ^a   Raghuram, G V ^a   Gupta, S ^a   Tiwari, S ^a   Upadhyaya, R ^b   Jain, S K ^c   Maudar, K K ^a  

^a BHOPAL MEMORIAL HOSPITAL AND RESEARCH CENTRE   (India)

^b Rajiv Gandhi Proudyogiki Vishwavidyalaya   (India)

^c DR H S GOUR UNIVERSITY   (India)

Author keywords

Apoptosis; DNA damage; Genomic instability; Inflammation; Isocyanates; Lung cancer

Indexed keywords

ATM PROTEIN; ATR PROTEIN; CYTOKINE; HISTONE H2AX; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; ISOCYANATE; LIPOCORTIN 5; N SUCCINIMIDYL N METHYLCARBAMATE; PERICENTRIN; PROTEIN P53; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; AUTACOID; ISOCYANIC ACID DERIVATIVE; METHYL ISOCYANATE;

AMINO ACID SEQUENCE; ANEUPLOIDY; APOPTOSIS; APOPTOTIC INDEX; ARTICLE; CENTROSOME; CHROMOSOMAL INSTABILITY; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOGENETICS; DNA DAMAGE; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; INFLAMMATION; INTER SIMPLE SEQUENCE REPEAT; LUNG FIBROBLAST; MICROSATELLITE INSTABILITY; MOLECULAR MECHANICS; PLOIDY; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; CYTOLOGY; DRUG EFFECT; FIBROBLAST; FLUORESCENT ANTIBODY TECHNIQUE; LUNG; METABOLISM; TIME; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; DNA DAMAGE; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE; GENOMIC INSTABILITY; HUMANS; INFLAMMATION MEDIATORS; ISOCYANATES; LUNG; TIME FACTORS;

EID: 66349125966     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/vol8-1gmr544     Document Type: Article

References (41)

1. Abraham RT (2004). PI 3-kinase related kinases: 'big' players in stress-induced signaling pathways. DNA Repair 3: 883-887.
2. Anderson D, Goyle S, Phillips BJ, Tee A, et al. (1988). Effects of methyl isocyanate on rat muscle cells in culture. Br. J. Ind. Med. 45: 269-274.
3. Baur X (2003). Isocyanates: occupational exposures and disorders. Pneumologie 57: 526-531.
4. Beyerbach A, Farmer PB and Sabbioni G (2006). Biomarkers for isocyanate exposure: Synthesis of isocyanate DNA adducts. Chem. Res. Toxicol. 19: 1611-1618.
5. Brody JS and Spira A (2006). State of the art. Chronic obstructive pulmonary disease, inflammation, and lung cancer. Proc. Am. Thorac. Soc. 3: 535-537.
6. Bumroongkit K, Rannala B, Traisathit P, Srikummool M, et al. (2008). TP53 gene mutations of lung cancer patients in upper northern Thailand and environmental risk factors. Cancer Genet. Cytogenet. 185: 20-27.
7. Chen D, Purohit A, Halilovic E, Doxsey SJ, et al. (2004). Centrosomal anchoring of protein kinase C betall by pericentrin controls microtubule organization, spindle function, and cytokinesis. J. Biol. Chem. 279: 4829-4839.
8. Coussens LM and Werb Z (2002). Inflammation and cancer. Nature 420: 860-867.
9. Doxsey S, Zimmerman W and Mikule K (2005). Centrosome control of the cell cycle. Trends Cell Biol. 15: 303-311.
10. Duesberg P, Li R, Fabarius A and Hehlmann R (2005). The chromosomal basis of cancer. Cell Oncol. 27: 293-318.
11. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, et al. (2005). Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434: 907-913.
12. Hofseth LJ, Khan MA, Ambrose M, Nikolayeva O, et al. (2003). The adaptive imbalance in base excision-repair enzymes generates microsatellite instability in chronic inflammation. J. Clin. Invest. 112: 1887-1894.
13. Ishikawa K, Ishii H and Saito T (2006). DNA damage-dependent cell cycle checkpoints and genomic stability. DNA Cell Biol. 25: 406-411.
14. Kang J, Ferguson D, Song H, Bassing C, et al. (2005). Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression. Mol. Cell Biol. 25: 661-670.
15. Kundu JK and Surh YJ (2008). Inflammation: gearing the journey to cancer. Mutat. Res. 659: 15-30.
16. Lee CT, Ylostalo J, Friedman M and Hoyle GW (2005). Gene expression profiling in mouse lung following polymeric hexamethylene diisocyanate exposure. Toxicol. Appl. Pharmacol. 205: 53-64.
17. Liloglou T, Maloney P, Xinarianos G, Hulbert M, et al. (2001). Cancer-specific genomic instability in bronchial lavage: a molecular tool for lung cancer detection. Cancer Res. 61: 1624-1628.
18. Mantovani A, Allavena P, Sica A and Balkwill F (2008). Cancer-related inflammation. Nature 454: 436-444.
19. Markovic J, Stojsic J, Zunic S, Ruzdijic S, et al. (2008). Genomic instability in patients with non-small cell lung cancer assessed by the arbitrarily primed polymerase chain reaction. Cancer Invest. 26: 262-268.
20. Martinez J, Oiry J, Imbach JL and Winternitz F (1982). Activated N-nitrosocarbamates for region selective synthesis of N-nitrosoureas. J. Med. Chem. 25: 178-182.
21. Mikoczy Z, Welinder H, Tinnerberg H and Hagmar L (2004). Cancer incidence and mortality of isocyanate exposed workers from the Swedish polyurethane foam industry: updated findings 1959-98. Occup. Environ. Med. 61: 432-437.
22. Mills KD, Ferguson DO and Alt FW (2003). The role of DNA breaks in genomic instability and tumorigenesis. Immunol. Rev. 194: 77-95.
23. Mishra PK, Panwar H, Bhargava A, Gorantla VR, et al. (2008). Isocyanates induces DNA damage, apoptosis, oxidative stress, and inflammation in cultured human lymphocytes. J. Biochem. Mol. Toxicol. 22: 429-440.
24. Ninomiya H, Nomura K, Satoh Y, Okumura S, et al. (2006). Genetic instability in lung cancer: concurrent analysis of chromosomal, mini- and microsatellite instability and loss of heterozygosity. Br. J. Cancer 94: 1485-1491.
25. O'Driscoll M, Ruiz-Perez VL, Woods CG, Jeggo PA, et al. (2003). A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome. Nat. Genet. 33: 497-501.
26. Pihan GA, Wallace J, Zhou Y and Doxsey SJ (2003). Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Res. 63: 1398-1404.
27. Piirila PL, Meuronen A, Majuri ML, Luukkonen R, et al. (2008). Inflammation and functional outcome in diisocyanate-induced asthma after cessation of exposure. Allergy 63: 583-591.
28. Rajagopalan H, Nowak MA, Vogelstein B and Lengauer C (2003). The significance of unstable chromosomes in colorectal cancer. Nat. Rev. Cancer 3: 695-701.
29. Redlich CA and Herrick CA (2008). Lung/skin connections in occupational lung disease. Curr. Opin. Allergy Clin. Immunol. 8: 115-119.
30. Schaefer DI, Livanos EM, White AE and Tlsty TD (1993). Multiple mechanisms of N-(phosphonoacetyl)-L-aspartate drug resistance in SV40-infected precrisis human fibroblasts. Cancer Res. 53: 4946-4951.
31. Schwartz AG, Prysak GM, Bock CH and Cote ML (2007). The molecular epidemiology of lung cancer. Carcinogenesis 28: 507-518.
32. Shiloh Y and Lehmann AR (2004). Maintaining integrity. Nat. Cell Biol. 6: 923-928.
33. Slatter JG, Rashed MS, Pearson PG, Han DH, et al. (1991). Biotransformation of methyl isocyanate in the rat. Evidence
34. for glutathione conjugation as a major pathway of metabolism and implications for isocyanate-mediated toxicities.
35. Chem. Res. Toxicol. 4: 157-161. Tibbetts RS, Brumbaugh KM, Williams JM, Sarkaria JN, et al. (1999). A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev. 13: 152-157.
36. Tseng RC, Hsieh FJ, Hsu HS and Wang YC (2008). Minimal deletion regions in lung squamous cell carcinoma: association with abnormality of the DNA double-strand break repair genes and their applications on gene identification and prognostic biomarkers. Lung Cancer 59: 332-339.
37. Vijayan VK and Sankaran K (1996). Relationship between lung inflammation, changes in lung function and severity of exposure in victims of the Bhopal tragedy. Eur. Respir. J. 9: 1977-1982.
38. Xiao H and Singh SV (2007). p53 regulates cellular responses to environmental carcinogen benzo[a]pyrene-7,8-diol-9,10-epoxide in human lung cancer cells. Cell Cycle 6: 1753-1761.
39. Xing J, Wu X, Vaporciyan AA, Spitz MR, et al. (2008). Prognostic significance of ataxia-telangiectasia mutated, DNA-dependent protein kinase catalytic subunit, and Ku heterodimeric regulatory complex 86-kD subunit expression in patients with nonsmall cell lung cancer. Cancer 112: 2756-2764.
40. Zhang X, Miao X, Guo Y, Tan W, et al. (2006). Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer. Hum. Mutat. 27: 110-117.
41. Zhou BB and Elledge SJ (2000). The DNA damage response: putting checkpoints in perspective. Nature 408: 433-439.